| JYSB1700130 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-07-06 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-10-12 | view |
| JYSB0900273 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2009-12-24 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2011-02-14 | view |
| CYSB2300011 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CXSL1700222 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-04-26 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2018-04-25 | view |
| CXSL1100007 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2011-03-30 | 珠海联邦制药股份有限公司中山分公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2013-04-11 | view |
| CYSB2400300 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-14 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2000109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CXSL1500127 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2016-03-30 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2017-04-20 | view |
| J0400579 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2004-09-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2004-11-03 | view |
| JYSB2200002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CYSB1700126 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-09-08 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-11-21 | view |
| JYSB0900236 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2010-02-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2011-02-16 | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| JYSZ1800051 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2018-10-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-08-15 | view |
| CXSL1300081 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2013-12-11 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2016-01-14 | view |
| CYSB2200005 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSS2200009 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-28 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXSL1700155 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-03-21 | 辽宁博鳌生物制药有限公司 | Liaoning Boao Biological Pharmaceutical Co Ltd | In Review | 2018-03-16 | view |
| JXSL1000013 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Import Drug Application | 2010-04-30 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2011-06-15 | view |
| CYSB2400288 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-05 | | Gan & Lee Pharmaceuticals | | | view |
